Heparin Induced Thrombocytopenia: A Novel Approach to Anticoagulation During Transcatheter Aortic Valve Replacement Utilizing Cangrelor

Daniel WaltersDepartment of Medicine, Division of Cardiovascular Medicine, University of California, San Diego, California, USACorrespondence[email protected]
View further author information

, MD,

Mitul PatelDepartment of Medicine, Division of Cardiovascular Medicine, University of California, San Diego, California, USAView further author information

, MD,

Eugene GoltsDepartment of Surgery, Division of Cardiothoracic Surgery, University of California, San Diego, California, USAView further author information

, MD,

Swapnil KhocheDepartment of Anesthesiology, University of California, San Diego, California, USAView further author information

, MD,

Ehtisham MahmudDepartment of Medicine, Division of Cardiovascular Medicine, University of California, San Diego, California, USAView further author information

, MD &

Ryan ReevesDepartment of Medicine, Division of Cardiovascular Medicine, University of California, San Diego, California, USAView further author information

, MD

References

Leon MB , Smith CR , Mack MJ , et al. Transcatheter or surgical aortic valve replacement in intermediate-risk patients. N Engl J Med . 2016;374:1609–1620. doi:10.1056/NEJMoa1514616.
PubMed Web of Science ®Google Scholar
Dangas GD , Lefevre T , Kupatt C , et al. Bivalirudin versus heparin anticoagulation in transcatheter aortic valve replacement: the randomized BRAVO-3 trial. J Am Coll Cardiol . 2015;66:2860–2868. doi:10.1016/j.jacc.2015.10.003.
PubMed Web of Science ®Google Scholar
Franchi F , Rollini F , Muniz-Lozano A , Cho JR , Angiolillo DJ. Cangrelor: a review on pharmacology and clinical trial development. Expert Rev Cardiovasc Ther . 2014;11(10):1279–1291. doi:10.1586/14779072.2013.837701.
Google Scholar
Storey RF , Oldroyd KG , Wilcox RG. Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndrome. Thromb Haemost . 2001;85(3):401–407. doi:10.1055/s-0037-1615596.
PubMed Web of Science ®Google Scholar
East JM , Cserti-Gazdewich CM , Granton JT . Heparin-induced thrombocytopenia in the critically ill patient. Chest . 2017. doi:10.1016/j.chest.2017.11.039.
Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Heparin Induced Thrombocytopenia: A Novel Approach to Anticoagulation During Transcatheter Aortic Valve Replacement Utilizing Cangrelor

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Heparin Induced Thrombocytopenia: A Novel Approach to Anticoagulation During Transcatheter Aortic Valve Replacement Utilizing Cangrelor

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date